Lundbeck VP joins board of migraine firm
Rehaler, which is developing a medical device to treat migraine episodes, has expanded its board with the addition of Bjørn Krogh Sperling, who is also spearheading Lundbeck’s migraine and pain research.
by albert rønning-andersson, translated by daniel pedersen
Rehaler, a migraine firm developing a medical device of the same name to treat migraine episodes, has expanded its board of directors with a Lundbeck leader, Bjørn Krogh Sperling, according to a filing on the Danish Central Business Register.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
